Abstract
Polymorphisms in the promoter region of the apolipoprotein E gene (APOE) affect the amount of amyloid peptide (A beta) in the brains of patients with Alzheimer's disease. We measured A beta load immunohistochemically in regions 8 and 9 of Brodman's area in 74 people with Alzheimer's disease. The amount of A beta deposition was independent of APOE genotype in our cohort. These findings in patients with confirmed Alzheimer's disease are consistent with the hypothesis that variation it; AWE expression directly affects Alzheimer's disease pathology.
| Original language | English |
|---|---|
| Pages (from-to) | 608-609 |
| Number of pages | 2 |
| Journal | Lancet |
| Volume | 357 |
| DOIs | |
| Publication status | Published - 1 Jan 2001 |
Fingerprint
Dive into the research topics of 'Impact of the APOE promoter polymorphisms on Aß deposition in Alzheimer's disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver